Mrudu Herbert

发表

Higher dosing of alglucosidase alfa improves outcomes in children with Pompe disease: a clinical study and review of the literature

M. ElMallah, K. Zimmerman, P. Kishnani, 2020, Genetics in Medicine.

Early-onset of symptoms and clinical course of Pompe disease associated with the c.-32-13 T > G variant.

P. Kishnani, L. Case, S. Austin, 2019, Molecular genetics and metabolism.

Response to de Vries et al.

A. Rosenberg, S. Richards, P. Kishnani, 2017, Genetics in Medicine.

Community perception regarding rabies prevention and stray dog control in urban slums in India.

Mrudu Herbert, S. Riyaz Basha, Selvi Thangaraj, 2012, Journal of infection and public health.

Role of continuous glucose monitoring in the management of glycogen storage disorders

P. Kishnani, Carine A. Halaby, S. Pendyal, 2018, Journal of Inherited Metabolic Disease.

Novel approaches to quantify CNS involvement in children with Pompe disease

J. Provenzale, G. Spiridigliozzi, K. Zimmerman, 2020, Neurology.

Improving Physician Referral for Tobacco Cessation Clients of Tobacco Cessation Clinic in South India

Mrudu Herbert, 2012 .

Severe Cardiac Involvement Is Rare in Patients with Late‐Onset Pompe Disease and the Common c.‐32‐13T>G Variant: Implications for Newborn Screening

Jennifer S. Li, P. Kishnani, Mrudu Herbert, 2018, The Journal of pediatrics.

Early-onset of symptoms and clinical course of Pompe disease associated with the c.-32-13 T > G variant.

P. Kishnani, L. Case, S. Austin, 2019, Molecular genetics and metabolism.